Christopher Yea sold $475K of KalVista Pharmaceuticals (KALV)

Executed Jul 9 2025, disclosed Jul 10 2025, 1 day later.

Value, as filed

$475K

30,250 sh × $15.69

Executed

Jul 9 2025

the trade date, as filed

Disclosed

Jul 10 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

CY Christopher Yea CHIEF DEVELOPMENT OFFICER profile →

Christopher Yea (CHIEF DEVELOPMENT OFFICER) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in KALV. The largest single filing was $905K of KALV (33,800 sh × $26.78, as filed), executed May 27.

The name

KALV KALV KALV · 19 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Christopher Yea in KALV

KALVSALE KalVista Pharmaceuticals, Inc. $905K
33,800 sh × $26.78
Exec May 27
Filed May 29 · 5:30 PM ET